NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Ganymed Robotics

Ganymed Robotics

Private
ParisHealthcare & Life Scienceshttps://www.ganymedrobotics.com/

Last Round

Debt

Jan 4, 2023

Total Funding Raised

$60.51M

Company Overview

Ganymed Robotics is a medical technology company that develops AI-powered robotic assistance platforms for orthopedic surgery.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical AI, Computer Vision, Industrial Robotics

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription

AI Layer

Application

Keywords

surgical roboticsorthopedic surgerycomputer visionrobot-assisted surgeryjoint replacementmedical roboticscomputer-assisted surgerysurgical navigationmedtechsurgical AIorthopedic roboticsintraoperative guidancemedical devicedigital surgery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ganymed Robotics Comps

Public and private peers based on sector, stage, and business model.

Ganymed Robotics comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Ganymed Robotics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
DebtJan 4, 2023
Series B ExtensionJan 4, 2023
Series BJul 7, 2022
GrantOct 14, 2021
GrantNov 23, 2020
Seed
Mar 10, 2020

Key People

Founding team and executive leadership

Sophie Cahen

Co-founder CEO (HIRING )

Founding Team

Ganymed Robotics Investors

Notable investors and investment history

Ganymed Robotics investors
InvestorRounds
CapHorn InvestSeries B Extension, Series B
Cathay CapitalSeries B
BNP Paribas DéveloppementSeries B
BpifranceSeries B Extension, Debt
EIT HealthAccelerator
Crédit Mutuel InnovationSeries B
CandriamSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 19, 2025

    Frédéric Banegas appointed to lead operations and interim CEO role.

  • Aug 19, 2025

    Michel Thérin appointed as new Executive Chairman.

Ganymed Robotics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Ganymed Robotics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Ganymed Robotics's valuation, stock price, and market status.

Firmographic Details

HeadquartersParis
Employee Range30
Year Founded2018
Last FundingJan 4, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.